Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: Retrospective analysis
Hai-Lin Li, Rui Zhao, Department of Hepatobiliary Surgery, Qilu Hospital, Shandong University, Jinan 250012, Shandong Province, China
Wen-Bin Ji, Wei-Dong Duan, Yong-Wei Chen, Xian-Qiang Wang, Qiang Yu, Ying Luo, Jia-Hong Dong, Hospital and Institute of Hepatobiliary Surgery, Chinese PLA General Hospital, Beijing 100853, China
Author contributions: Li HL and Dong JH designed research; Li HL, Dong JH, Ji WB, Duan WD, Chen YW, Yu Q and Luo Y performed research; Li HL, Ji WB, Duan WD, Zhao R, Wang XQ, Yu Q and Luo Y contributed analytical tools; Li HL and Ji WB analyzed data; and Li HL wrote the paper.
Supported by National Science and Technology Major Project for Infectious Diseases of China, No. 2012ZX10002-017; National Key Technology Research And Development Program of China, No. 2012BAI06B01; and the Grants from Natural Science Foundation of China, No. 81302123.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Jia-Hong Dong, MD, PhD, FACS, Hospital and Institute of Hepatobiliary Surgery, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing 100853, China. email@example.com
Telephone: +86-10-66938030 Fax: +86-10-68241383
Received: July 13, 2014
Peer-review started: July 13, 2014
First decision: August 15, 2014
Revised: September 30, 2014
Accepted: October 21, 2014
Article in press: October 21, 2014
Published online: March 28, 2015